Work

Reply

Year: 2019

Type: letter

Source: JACC Heart Failure

DOI: 10.1016/j.jchf.2019.08.009

Authors: Masatoshi Minamisawa, Sara B. Seidelmann, Scott D. Solomon

Institution: National Institutes of Health

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Health and Human Services, Amgen, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Sanofi, Gilead Sciences, Alnylam Pharmaceuticals, Celladon Corporation, Cytokinetics, MyoKardia, Japanese Society of Echocardiography, Japanese Circulation Society, National Institutes of Health, Sanofi Pasteur, National Heart, Lung, and Blood Institute

Award: G885818904

OpenAlex ID: W2985255049

Cites: 6

Cited by:

Related to: 10